Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **mucociliary system** refers to the airway mucosa's specialized apparatus for trapping and expelling inhaled particulates and pathogens via a tightly coordinated mechanism. It consists of ciliated cells that beat in synchronized waves, propelling a protective mucous layer upwards toward the pharynx for removal. This system relies on multiciliated epithelial cells (each with ~200 cilia beating ~10–20 times per second), a two-layer airway surface liquid (ASL) with a gel-like mucus layer and a low-viscosity periciliary layer (PCL), and ion channels (CFTR, ENaC) maintaining optimal hydration. Disease occurs when this system is impaired, as in ciliopathies (e.g., primary ciliary dyskinesia), cystic fibrosis (disrupted mucus properties and hydration), and chronic airway disease. The system’s proper function is essential for pulmonary health, hygiene, and defense against infection[1][2][3][7][8].
Not applicable to the system as a whole; drugs may restore mucus hydration, modulate ion channels, or increase ciliary motility
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mucociliary apparatus (or mucociliary clearance mechanism) (MCC).